Bristol Myers Squibb Provides Update on Phase 3 RELATIVITY-098 Trial
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/14/2026
- Nasdaq ends sharply lower as hot inflation data stirs rate-hike worries
- Oil prices gain on attacks in Saudi Arabia, Iran's new tactics to target tankers
- U.S. consumer prices rise by 3.7% year-on-year in September
- Bank of America stock falls on earnings miss
- Netflix cuts 1,000 jobs as streaming giant seeks to boost engagement
| Bristol-Myers Squibb (NYSE: BMY) | Delayed: 59.28 +2.61 (4.61%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $56.67 | 52 Week High | $77.12 | |||
| Open | $56.81 | 52 Week Low | $49.03 | |||
| Day High | $59.39 | P/E | 38.49 | |||
| Day Low | $56.58 | EPS | $1.54 | |||
| Volume | 13,691,359 | |||||
